Affiliation:
1. School of Biotechnology Jiangnan University Wuxi 214122 China
2. Key Laboratory of Industrial Biotechnology of Ministry of Education Jiangnan University Wuxi 214122 China
3. School of Life Sciences and Health Engineering Jiangnan University Wuxi 214122 China
Abstract
AbstractThe synthetic pathway for Etiracetam depends on alpha‐ethyl‐2‐oxo‐1‐pyrrolidineacetic acid (AEOPA) as a crucial intermediate. This paper presents an enzymatic synthesis approach for producing (R)‐AEOPA. Through database mining, we discovered a tauriopine dehydrogenase capable of catalyzing the reaction between γ‐aminobutyric acid and 2‐oxobutyric acid, resulting in the synthesis of (R)‐4‐(carboxypropylamino) butyric acid with a specific activity of 6.74 U/mg. By enhancing substrate affinity and catalytic efficiency of CgTaDH through protein engineering, we achieved a 5.9‐fold increase in enzyme activity compared to the wild type. Further optimization led to a space‐time yield (STY) of 3.95 g/L/h for (R)‐4‐(carboxypropyl amino) butyric acid and a high yield of 73.0 % for the final product, (R)‐AEOPA. This study demonstrates a novel synthesis method for (R)‐AEOPA and highlights the potential of biocatalysis in improving the production of Etiracetam through successful enzymatic processes.
Reference28 articles.
1. Multicomponent Chiral Quantification with Ultraviolet Circular Dichroism Spectroscopy: Ternary and Quaternary Phase Diagrams of Levetiracetam
2.
3. J. Gobert; C. Giurgea; J. P. Geerts; G. Bodson EP0165919A1 1985;
4. B. R. Guntoori Z. X. Wang Y. Q. Li CA2488325A1 2004;
5. J. Gobert C. Giugi; J. P. Gittes G. Bodson CN85105307 1987.